Mirae Asset Global ETFs Holdings’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$938K Buy
78,364
+20,014
+34% +$166K ﹤0.01% 1666
2026
Q1
$486K Buy
58,350
+3,605
+7% +$37.9K ﹤0.01% 1902
2025
Q4
$787K Sell
54,745
-488
-0.9% -$6.08K ﹤0.01% 1652
2025
Q3
$534K Sell
55,233
-4,218
-7% -$37.3K ﹤0.01% 1841
2025
Q2
$489K Sell
59,451
-34,315
-37% -$287K ﹤0.01% 1831
2025
Q1
$670K Sell
93,766
-6,686
-7% -$49.7K ﹤0.01% 1705
2024
Q4
$775K Buy
100,452
+2,827
+3% +$26.5K ﹤0.01% 1688
2024
Q3
$1.03M Sell
97,625
-12,100
-11% -$148K ﹤0.01% 1530
2024
Q2
$1.28M Buy
+109,725
New +$1.71M ﹤0.01% 1322

Other funds holding RGNX

Mirae Asset Global ETFs Holdings's RGNX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Regenxbio (RGNX) stake by 34% in Q2 2026, buying an estimated $166K and bringing the position to 78,364 shares worth $938K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Mirae Asset Global ETFs Holdings first reported a position in RGNX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.28M in Q2 2024. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 78,364 shares of Regenxbio worth $938K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 20,014 Regenxbio shares in Q2 2026, an estimated $166K.
  • Regenxbio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1666 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Regenxbio in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Regenxbio position peaked at $1.28M in Q2 2024.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.